Service Overview: Proprietary Diagnostic Solutions
We design and develop lateral flow assays(LFAs) tests that are non-invasive, rapid, and supported by integration of different biomarkers into AI algorithms for
improved accuracy. Our primary focus areas include Ovarian cancer, Colorectal and lung cancer three areas with
significant unmet diagnostic needs.Besides these we focus on assays that provide one solution to assess the bladder
health as well as gut health status. We also develop quick assays that could assist clinicians for early diagnosis and
treatment monitoring of cancers in dogs as well as cats.